Although there have been tens of millions of confirmed cases, investigations of the disease are still not adequate and more clinical reports are urgently needed to share with medical staffs all over the world. Thus, Chinese experience in battling with COVID-19 disease could be generalizable to patients in other countries. Procedures for COVID-19 detection and medical therapy are also described in detail. In addition, the New Coronavirus Pneumonia Diagnosis and Treatment Plan by the China National Health Commission (CNHC) also plays vital roles in the control and prevention of COVID-19 in China, which is revised regularly based on clinical experience and findings. According to the real-time data released by the Coronavirus Resource Center at the Johns Hopkins University and Medicine ( ), it seems that the outbreak in China has been contained, with rarely new local infections, which, though still disputable, may indicate that the lockdown and mask-wearing policies have positive effects on slowing down and blocking the spread of the virus. So far, the COVID-19 pandemic is still ongoing and the causing virus SARS-CoV-2 is under extensive investigation in terms of its transmission routes ( 2- 4), infection mechanisms ( 5), genomic evolution ( 6), and environmental viability ( 7). Since the first officially reported case of the coronavirus disease 2019 (COVID-19) in late December, 2019 in Wuhan, China, the outbreak has evolved into a global public health crisis with an extensive number of infected patients, causing devastating death toll all over the world ( 1). Keywords: Coronavirus disease 2019 (COVID-19) SARS-CoV-2 infection symptom transmission medical treatment Some of the laboratory markers were statistically different during the course of the disease, which might serve as indicators in identifying patients with COVID-19 disease at an early stage of the infection. After medical treatment, all patients were discharged home and recovering from the infection.Ĭonclusions: This study provides a comprehensive overview of patients with COVID-19 disease in a single hospital.
Laboratory markers were identified due to temporal changes.
Results: Epidemiological features and clinical findings were present for all 25 patients. In addition, laboratory markers were investigated in terms of course of treatment. Epidemiological characterizations, clinical findings, and medical treatments were all reported. Methods: In this retrospective, single-center cohort analysis, we included 25 adult inpatients with laboratory confirmed COVID-19 disease from the affiliated hospital of Xuzhou Medical University (Xuzhou, China). So far, the pandemic is ongoing globally, and the situation is still worsening. #These authors contributed equally to this work.īackground: The coronavirus disease 2019 (COVID-19) is spreading rapidly across countries and has infected tens of millions of people all over the world.
0 kommentar(er)
